# Phase 2/3 syndrome trials recruiting: 43 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 43 trials in phase 2/3 for syndrome that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2/3 syndrome trials: 43 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2-3/syndrome

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 43
- Recruiting or not yet: 43
- Read on: November 19, 2026

## Trials

The 25 newest of 43, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07932548 | Clinical Efficacy of Acupuncture and Paraffin Wax Therapy in the Treatment of Carpal Tunnel Syndrome | The University of Health Sciences, VNU-HCM | Phase 2/3 | Not yet recruiting | Carpal Tunnel Syndrome (CTS) | 177 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932548) |
| October 23, 2026 | NCT07892664 | Reducing Arterial Inflammation Using Eplerenone and Statins in HIV | Massachusetts General Hospital | Phase 2/3 | Not yet recruiting | HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892664) |
| October 6, 2026 | NCT07860021 | VYVGART (Hytrulo) in Patients With Stiff Person Syndrome (SPS) | Thomas Jefferson University | Phase 2/3 | Recruiting | Stiff Person Syndrome | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860021) |
| September 1, 2026 | NCT07797036 | Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus | University of Massachusetts, Worcester | Phase 2/3 | Not yet recruiting | Gestational Diabetes Mellitus (GDM), Metabolic Syndrome | 226 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797036) |
| July 7, 2026 | NCT07686770 | Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease | Children's Hospital of Fudan University | Phase 2/3 | Not yet recruiting | Kawasaki Disease | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686770) |
| June 18, 2026 | NCT07656909 | Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP | Sponsor not shown (see the record) | Phase 2/3 | Recruiting | Kaposiform Hemangioendothelioma (KHE), Kasabach Merritt Phenomenon | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07656909) |
| June 4, 2026 | NCT07625332 | Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) | Northwell Health | Phase 2/3 | Recruiting | Spinal Cord Injury, Traumatic Spinal Cord Injury, Paraplegia and Tetraplegia, Metabolic Syndrome | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625332) |
| May 26, 2026 | NCT07606014 | No Guts No Glory Probiotics | University Medical Center Groningen | Phase 2/3 | Recruiting | Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606014) |
| April 20, 2026 | NCT07538583 | Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome | Quoin Pharmaceuticals | Phase 2/3 | Recruiting | Netherton Syndrome | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07538583) |
| April 17, 2026 | NCT07537998 | Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center... | Sponsor not shown (see the record) | Phase 2/3 | Recruiting | Low Anterior Resection Syndrome, Rectal Cancer | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537998) |
| March 30, 2026 | NCT07502118 | NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19) | Health Institutes of Turkey | Phase 2/3 | Recruiting | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL), Relapsed/Refractory Non-Hodgkin Lymphoma, Diffuse... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502118) |
| March 25, 2026 | NCT07493785 | Dexmedetomidine for Invasive Ventilation In the NEOnate | Centre Hospitalier Intercommunal Creteil | Phase 2/3 | Not yet recruiting | Invasive Ventilation, Infant Pain, Infant Discomfort, Infant Neurodevelopment, Neonatal Respiratory Failure | 246 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07493785) |
| February 27, 2026 | NCT07439510 | A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS | Spinogenix | Phase 2/3 | Not yet recruiting | Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439510) |
| January 15, 2026 | NCT07342205 | A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation | Shanghai University of Traditional Chinese Medicine | Phase 2/3 | Recruiting | Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07342205) |
| December 11, 2025 | NCT07277582 | Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) | Thryv Therapeutics | Phase 2/3 | Recruiting | Long QT Syndrome (LQTS) 2 | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277582) |
| December 5, 2025 | NCT07266831 | A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) | Merck Sharp & Dohme LLC | Phase 2/3 | Recruiting | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266831) |
| December 2, 2025 | NCT07257978 | Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome | Fenix Innovation Group | Phase 2/3 | Not yet recruiting | RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07257978) |
| October 9, 2025 | NCT07214818 | SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome | Mansoura University | Phase 2/3 | Recruiting | Nephrotic Syndrome | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214818) |
| September 30, 2025 | NCT07199504 | A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole | Sponsor not shown (see the record) | Phase 2/3 | Recruiting | Restless Leg Syndrome Due to Uraemia | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07199504) |
| May 15, 2025 | NCT06974084 | A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of... | HealthBio, Inc. | Phase 2/3 | Not yet recruiting | Long COVID | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06974084) |
| May 1, 2025 | NCT06953466 | Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome | Quoin Pharmaceuticals | Phase 2/3 | Recruiting | Netherton Syndrome | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06953466) |
| March 20, 2025 | NCT06885762 | Efgartigimod for the Treatment of Guillain-Barré Syndrome | Sponsor not shown (see the record) | Phase 2/3 | Not yet recruiting | Guillain-Barre Syndrome (GBS) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06885762) |
| January 23, 2025 | NCT06789783 | Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment | University of Milan | Phase 2/3 | Recruiting | Cornelia De Lange Syndrome | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06789783) |
| January 23, 2025 | NCT06788990 | FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC | Bicara Therapeutics | Phase 2/3 | Recruiting | Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06788990) |
| January 6, 2025 | NCT06758830 | Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | Phase 2/3 | Recruiting | Rectal Cancer, Total Neoadjuvant Treatment, Neoadjuvant Therapy, Radiotherapy, Chemotherapy, Organ Preservation... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06758830) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Quoin Pharmaceuticals | 3 |
| University of Aarhus | 1 |
| Chulalongkorn University | 1 |
| Centre Hospitalier Intercommunal Creteil | 1 |
| Bicara Therapeutics | 1 |
| University of Milan | 1 |
| Mansoura University | 1 |
| University of Alberta | 1 |
| National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | 1 |
| Hellenic Institute for the Study of Sepsis | 1 |
| University of Monastir | 1 |
| Massachusetts General Hospital | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| Children's Hospital of Fudan University | 1 |
| University of Michigan | 1 |
| VA Office of Research and Development | 1 |
| Resverlogix Corp | 1 |
| University Medical Center Groningen | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Fenix Innovation Group | 1 |
| Spinogenix | 1 |
| HealthBio, Inc. | 1 |
| Medical University of South Carolina | 1 |
| [Guangdong Hengrui Pharmaceutical Co., Ltd](https://specstream.ai/data/clinical-trials/company/guangdong-hengrui-pharmaceutical-co-ltd) | 1 |
| Northwell Health | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 14 |
| China | 7 |
| France | 3 |
| Canada | 3 |
| Italy | 3 |
| Spain | 3 |
| United Kingdom | 3 |
| Thailand | 2 |
| Belgium | 2 |
| Argentina | 2 |
| Australia | 2 |
| Brazil | 2 |
| Germany | 2 |
| Greece | 2 |
| Poland | 2 |
| Switzerland | 2 |
| Turkey (Türkiye) | 2 |
| Denmark | 1 |
| Austria | 1 |
| Czechia | 1 |
| India | 1 |
| Ireland | 1 |
| Israel | 1 |
| Japan | 1 |
| Malaysia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Physical therapy clinics in the United States](https://specstream.ai/data/businesses/physical-therapy-clinics/united-states)
- [Spring suppliers in the United States](https://specstream.ai/data/businesses/spring-suppliers/united-states)
- [African restaurants in the United States](https://specstream.ai/data/businesses/african-restaurants/united-states)
- [Business banking companies in the United States](https://specstream.ai/data/businesses/business-banking-companies/united-states)
- [Educational research institutes in the United States](https://specstream.ai/data/businesses/educational-research-institutes/united-states)
- [Home network installers in the United States](https://specstream.ai/data/businesses/home-network-installers/united-states)
